Laboratory Billing Services for Clinical Tests, CLIA Claims, Denials, and AR Recovery
ClaraRCM provides laboratory billing services for independent laboratories, physician office laboratories, hospital outreach laboratories, molecular testing programs, and multispecialty groups across the United States. Our team manages order validation, medical necessity, CPT and HCPCS coding, CLIA data, clean claims, payment posting, denials, underpayments, and accounts receivable.
Updated July 2026 for the CMS Clinical Laboratory Fee Schedule, current PAMA reporting, CLIA claim controls, medical necessity documentation, and laboratory denial prevention.
Get a Free Laboratory Billing Audit
See where missing order support, medical necessity edits, CLIA issues, panel coding, payer underpayments, and aging claims are reducing laboratory revenue.
What Is Laboratory Billing, and Why Are Lab Claims Denied?
In brief: Laboratory billing converts a supported test order and specimen record into a payer compliant claim. The central control points are intent to order, medical necessity, CPT and HCPCS selection, panel logic, CLIA information, reference laboratory rules, payer policy, payment posting, and denial follow up.
Laboratory billing is the revenue cycle process that converts a supported test order, specimen record, result, diagnosis, laboratory code, CLIA information, and payer rule into a clean claim and verified payment.
Laboratory claims are high volume and often low dollar, so small errors can create significant revenue loss. Missing order support, weak diagnosis linkage, panel unbundling, wrong CLIA data, reference testing errors, and payer coverage edits can affect thousands of claims before the pattern is noticed.
Our team reconciles orders, accession data, diagnoses, test codes, modifiers, CLIA information, payer edits, remittance details, underpayments, and aging balances so laboratory revenue does not remain trapped in accounts receivable.
| Laboratory Billing Problem | ClaraRCM Control |
|---|---|
| Medical record does not support intent to order the specific test | Order, authenticated note, ordering provider, and test match review |
| Diagnosis does not support payer medical necessity policy | Diagnosis linkage and coverage policy validation before submission |
| CLIA number is missing, inactive, or tied to the wrong location | CLIA certificate and performing location validation |
| Panel components are billed separately without support | Panel, component, and payer bundling review |
| Reference laboratory test lacks the correct billing treatment | Performing laboratory, modifier 90, result, and contract review |
| Low dollar denials accumulate without focused follow up | Root cause grouping, automated work queues, and payer level escalation |
Laboratory Medical Necessity and Missing Charge Calculator
Estimate annual revenue exposure from unrecovered order or medical necessity denials and from completed tests that do not reach the billing system because of interface, accession, or charge capture gaps.
Estimated annual revenue exposure from unrecovered laboratory denials and missed test charges.
The starting values are illustrative, not industry benchmarks. Actual results depend on payer mix, test menu, contracted rates, order quality, diagnosis support, CLIA status, panel rules, interfaces, appeal success, and recovery timing.
Send Your Calculator Results to ClaraRCM
Our team will review the inputs and identify where order documentation, medical necessity, CLIA edits, missed charges, denials, underpayments, or aging AR may deserve attention.
Laboratory CPT and HCPCS Code Reference With Medicare Payment Ranges
The table uses paraphrased descriptions and rounded 2026 Medicare Clinical Laboratory Fee Schedule payment direction. Actual payment depends on code status, coverage, date of service, payer policy, and the current CMS file.
| Code | Short Description | Approximate 2026 Medicare Range | Key Billing Control |
|---|---|---|---|
| 80048 | Basic metabolic panel | $8 to $14 | Bill the panel when all required components are performed |
| 80053 | Comprehensive metabolic panel | $10 to $17 | Avoid unsupported separate component billing |
| 80061 | Lipid panel | $12 to $20 | Confirm coverage frequency and diagnosis support |
| 81001 | Automated urinalysis with microscopy | $3 to $8 | Match methodology and microscopy performance |
| 82306 | Vitamin D, 25 hydroxy test | $25 to $40 | Medical necessity policies can be restrictive |
| 83036 | Hemoglobin A1c | $8 to $15 | Review frequency, diagnosis, and point of care status |
| 84153 | Total prostate specific antigen | $18 to $30 | Distinguish screening and diagnostic coverage rules |
| 84443 | Thyroid stimulating hormone | $20 to $32 | Support diagnosis and repeat testing frequency |
| 85025 | Complete blood count with automated differential | $7 to $13 | Report the code matching the performed components |
| 87086 | Urine culture with colony count | $10 to $20 | Separate identification and susceptibility rules may apply |
| 87491 | Chlamydia nucleic acid test | $30 to $50 | Confirm method, specimen, diagnosis, and payer coverage |
| 87591 | Gonorrhea nucleic acid test | $30 to $50 | Validate code pairing and screening coverage |
| 87635 | Single target infectious agent molecular test | $30 to $52 | Confirm current code status and payer medical necessity |
| 87880 | Rapid infectious agent antigen test | $15 to $25 | Use modifier QW only when applicable to the test and certificate |
| 36415 | Routine venipuncture collection | $3 to $6 | Collection payment and bundling vary by setting and payer |
How ClaraRCM Manages Laboratory Medical Billing
Order and Eligibility Validation
We validate coverage, ordering provider data, intent to order, medical necessity support, test details, specimen date, performing location, and payer requirements.
Code, Panel, and CLIA Review
We review CPT and HCPCS codes, panels, components, modifiers 90 and 91, QW status, CLIA information, diagnosis linkage, and reference testing rules.
Clean Claim and Payment Posting
We submit validated claims, post ERA and EOB details, reconcile contracted amounts, and flag denials or payments that do not match expected terms.
Denial, Underpayment, and AR Work
We group denials by root cause, correct supported claims, appeal payer reductions, investigate underpayments, and work aging balances through final disposition.
Why Laboratories Choose ClaraRCM
Laboratory Specific Billing Controls
We manage high volume test claims with attention to orders, medical necessity, panels, CLIA data, reference testing, and payer policy.
97% Clean Claim Rate
Our workflow emphasizes complete data, payer edits, test level validation, and preventable denial control before submission.
LIS and Charge Reconciliation
We compare order, accession, result, charge, and claim data to identify completed tests that never reached billing.
Denial Root Cause Ownership
We separate order, medical necessity, CLIA, bundling, enrollment, eligibility, and payer policy denials so corrections address the real cause.
All 50 States
ClaraRCM supports more than 500 providers nationwide with payer focused billing, posting, follow up, and reporting workflows.
35% Average AR Reduction
We combine denial correction, payer follow up, underpayment review, aging analysis, and work queue accountability to reduce unpaid balances.
Before ClaraRCM and After ClaraRCM
| Laboratory Revenue Metric | Before | After ClaraRCM |
|---|---|---|
| Clean claim performance | Frequent order, diagnosis, CLIA, and payer edit failures | 97% clean claim rate |
| Collection performance | Low dollar denials and underpayments remain unresolved | 98.5% collection ratio |
| Accounts receivable | Aging balances grow across test categories and payer queues | 35% average AR reduction |
| Reimbursement speed | Claims wait for missing data, correction, or manual follow up | 14 days average reimbursement |
| Charge capture | LIS, accession, result, and billing records are not reconciled | Routine test and claim reconciliation |
| Denial prevention | Teams correct individual claims without tracking recurring causes | Payer and root cause trend controls |
Performance figures reflect ClaraRCM aggregate client results across specialties. Individual laboratory outcomes vary by payer mix, test menu, claim volume, documentation quality, contracts, systems, and starting AR baseline.
Independent Laboratory Billing vs Hospital Outreach Laboratory Billing
Both models bill diagnostic testing, but their enrollment, claim format, payer contracts, Medicare reporting analysis, and revenue ownership can differ. The correct workflow depends on the entity that performs the test and the entity authorized to bill it.
| Factor | Independent Laboratory Billing | Hospital Outreach Laboratory Billing |
|---|---|---|
| Typical Medicare billing path | Usually bills under the laboratory's own NPI | May bill Medicare Part B on institutional type of bill 14X |
| Patient setting | Receives specimens from practices, facilities, or direct access channels | Serves patients who are not admitted inpatients or registered hospital outpatients |
| Claim format | Commonly professional or laboratory claim workflows | Often institutional claim workflows for qualifying outreach services |
| PAMA analysis | Determined using the laboratory NPI and TIN structure | May use 14X revenue data when determining applicable laboratory status |
| Contract focus | Independent laboratory network and test menu contracts | Hospital, outreach, network, and institutional contract terms |
| Primary control point | Ordering data, CLIA, test coding, reference work, and payer edits | Outreach patient status, claim type, 14X logic, order support, and contract treatment |
Billing Services for Related Medical Specialties
Revenue Cycle Services That Support Laboratories
Denial Management
Resolve medical necessity, order, CLIA, panel, eligibility, payer policy, and timely filing denials by root cause.
Learn more →Primary Care Billing
Improve order data, diagnosis support, preventive testing, and claim coordination with referring primary care practices.
Learn more →FQHC and Rural Health Clinic Billing
Support laboratories serving community health, rural care, outreach, and integrated diagnostic workflows.
Learn more →Emergency Room Billing
Coordinate laboratory charges and claim data with emergency encounters, facility records, and medical necessity documentation.
Learn more →Laboratory Billing Questions About Codes, CLIA, Denials, and Benchmarks
Laboratory billing is the revenue cycle process that converts a supported test order, specimen record, result, diagnosis, CPT or HCPCS code, CLIA information, and payer rule into a clean claim. It also includes payment posting, denial appeals, underpayment review, patient responsibility, and accounts receivable follow up.
Medicare pays most clinical diagnostic laboratory tests under the Clinical Laboratory Fee Schedule. Payment is generally based on the applicable national fee schedule amount, subject to coverage, medical necessity, code status, date of service, and billing requirements. Inclusion on a fee schedule does not by itself guarantee coverage or payment.
Laboratory claims are commonly denied because the record does not support intent to order, medical necessity is unclear, diagnosis coding does not meet coverage policy, the CLIA number or modifier is wrong, a panel is unbundled, a reference laboratory rule is missed, or the ordering provider and claim data do not match.
Medicare laboratory documentation should support the treating provider's intent to order the specific test and the medical necessity of the service. The billing entity should retain the order, ordering provider information, diagnosis or narrative support, evidence of accurate order processing, claim details, and test result documentation when required for review.
Modifier 90 identifies a laboratory test performed by an outside reference laboratory when the billing arrangement and payer rules allow the referring laboratory to report the service. The claim, order, result, and reference laboratory relationship must be traceable. Some payers apply additional enrollment, place of service, or purchased service requirements.
Modifier 91 is used when the same clinical laboratory test is repeated on the same date to obtain subsequent medically necessary results. It should not be used for a rerun caused by equipment error, specimen quality problems, or confirmation of an initial result when payer policy treats the work as part of the original test.
A laboratory must hold the appropriate CLIA certificate for the testing it performs. CMS states that laboratories must be properly certified to receive Medicare or Medicaid payment. Claims can fail when the CLIA number is missing, inactive, associated with the wrong location, or does not support the complexity of the reported test.
An independent laboratory generally bills under its own NPI and laboratory enrollment. A hospital outreach laboratory serves patients who are not admitted inpatients or registered outpatients and may bill Medicare Part B on institutional type of bill 14X. Enrollment, claim format, payer contracts, and PAMA reporting analysis can therefore differ.
Clinical laboratory billing commonly covers chemistry, hematology, microbiology, molecular, toxicology, and other diagnostic testing. Pathology billing may include professional interpretation, technical processing, specimen specific services, and global or component billing. The documentation, modifiers, place of service, and fee schedule can differ even when both services originate in a laboratory.
A signature is not always required on the laboratory order itself, but the medical record must clearly support the treating provider's intent to order the test and its medical necessity. An unsigned requisition alone may be insufficient. The ordering record, authenticated clinical note, or other permitted documentation must support the specific tests billed.
A laboratory billing team should track clean claim rate, rejection rate, medical necessity denials, missing order denials, CLIA edits, panel bundling, reference laboratory denials, average allowed amount, net collection ratio, payment variance, appeal overturn rate, days in accounts receivable, and aging by payer, test category, and ordering source.
Outsourcing can be worthwhile when a laboratory needs specialized coverage for CLFS rules, CLIA data, medical necessity, payer edits, reference testing, high claim volume, payment posting, and denial follow up. The decision should compare total internal staffing cost, coverage gaps, technology integration, reporting depth, compliance controls, and measurable collection performance.